| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.17 | 8e-07 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-06 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |